Recurrent episodes of pneumonia are associated with worse lung function in people with HIV

BACKGROUND: HIV is associated with a decreased diffusing capacity for carbon monoxide (DLco), decreased spirometry, and an increased risk for developing obstructive lung disease, even in never-smokers. Pneumonia is a risk factor for impaired pulmonary function in people with HIV (PWH), but whether recurrent pneumonia results in a commensurate decline in lung function is unknown. METHODS: We reviewed the electronic medical records and PFT data for PWH in San Francisco, CA. Participants were categorized by number of pneumonias since HIV diagnosis. We analyzed the association between the number of pneumonias and lung function using linear and logistic regression models after adjusting for substance use and HIV-associated factors. RESULTS: Among 259 participants, the mean age was 51 years, 15% were female, and 42% were current smokers. One hundred (39%) participants had no prior pneumonia, 52 (20%) had 1 pneumonia, 50 (19%) had 2 pneumonias and 57 (22%) had ≥3 pneumonias. Multiple pneumonias were associated with a stepwise decline in FEV1, FVC, and DLCO %predicted (p-trend <0.001 for all) when controlling for demographic and clinical covariates. Having ≥3 pneumonias was associated with 2.84 higher odds of airflow obstruction (post-bronchodilator FEV1/FVC < LLN, 95% CI 1.02, 8.23) as well as 5.53 higher odds of impaired DLco (DLco < LLN, 95% CI 2.29, 14.0) compared to those who never had pneumonia. There were no significant differences in PFT outcomes between participants with bacterial pneumonia versus Pneumocystis pneumonia during their first episode. CONCLUSION: In PWH with a high prevalence of inhalational substance use, recurrent episodes of pneumonia are associated with a commensurate decline in lung function in PWH characterized by airflow obstruction and diffusion limitations. While further studies are needed to elucidate the underlying mechanism, this work highlights the importance of preventing recurrent pneumonia in PWH in order to preserve lung function.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2026-04-13
DOI
https://doi.org/10.1371/journal.pone.0344756
Primary Topic
Pneumocystis jirovecii pneumonia detection and treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Recurrent episodes of pneumonia are associated with worse lung function in people with HIV

Amanda Jan, K. Gardner, Rebecca Abelman, Sven Walderich et al.
PLoS ONE
Pneumocystis jirovecii pneumonia detection and treatment
article

Recurrent episodes of pneumonia are associated with worse lung function in people with HIV

Amanda Jan, K. Gardner, Rebecca Abelman, Sven Walderich, Michelle Zhang, Sharvari Bhide, Laurence Huang, Katerina L. Byanova, Aryana Bates, Jessica Fitzpatrick-Collins, Jake Branchini
article en

Abstract

BACKGROUND: HIV is associated with a decreased diffusing capacity for carbon monoxide (DLco), decreased spirometry, and an increased risk for developing obstructive lung disease, even in never-smokers. Pneumonia is a risk factor for impaired pulmonary function in people with HIV (PWH), but whether recurrent pneumonia results in a commensurate decline in lung function is unknown. METHODS: We reviewed the electronic medical records and PFT data for PWH in San Francisco, CA. Participants were categorized by number of pneumonias since HIV diagnosis. We analyzed the association between the number of pneumonias and lung function using linear and logistic regression models after adjusting for substance use and HIV-associated factors. RESULTS: Among 259 participants, the mean age was 51 years, 15% were female, and 42% were current smokers. One hundred (39%) participants had no prior pneumonia, 52 (20%) had 1 pneumonia, 50 (19%) had 2 pneumonias and 57 (22%) had ≥3 pneumonias. Multiple pneumonias were associated with a stepwise decline in FEV1, FVC, and DLCO %predicted (p-trend <0.001 for all) when controlling for demographic and clinical covariates. Having ≥3 pneumonias was associated with 2.84 higher odds of airflow obstruction (post-bronchodilator FEV1/FVC < LLN, 95% CI 1.02, 8.23) as well as 5.53 higher odds of impaired DLco (DLco < LLN, 95% CI 2.29, 14.0) compared to those who never had pneumonia. There were no significant differences in PFT outcomes between participants with bacterial pneumonia versus Pneumocystis pneumonia during their first episode. CONCLUSION: In PWH with a high prevalence of inhalational substance use, recurrent episodes of pneumonia are associated with a commensurate decline in lung function in PWH characterized by airflow obstruction and diffusion limitations. While further studies are needed to elucidate the underlying mechanism, this work highlights the importance of preventing recurrent pneumonia in PWH in order to preserve lung function.

PLoS ONEVol. 21(4)
University of California, San Francisco (US), University of California System (US), San Francisco VA Health Care System (US)
National Institutes of Health, National Heart, Lung, and Blood Institute
Good health and well-being
Openalex Percentile: Top 17%
Pneumocystis jirovecii pneumonia detection and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.